Author: Katie Dale With the huge effort that’s currently being spent developing more resistant T cell therapies with new targets and increased efficacy against solid tumours, it’s easy to overlook the toxicity concerns and the innovative ways scientists are tackling…
By Vered Smith Glaucoma is a condition that affects approximately 70 million people worldwide¹, –a number greater than all the people living in the U. K². But scientists led by Jiahui Wu from the University of Bristol, have come up…
By Anitta Rose Chacko Most of us may have experienced feeling on edge whilst playing the classic tumbling tower game of Jenga. Particularly, when it is your turn to remove a block from the tower and place it on the…
By Felicity Crawshay-Williams Before the start of World War ll in 1939, it became apparent to the Allies that the Germans were transmitting encrypted radio messages. Polish intelligence later informed the British that the secret messages took the form of…
By Christopher Smith Hello reader, I hope that you’re well, And that you have a few moments to dwell, To learn about my Post Doc project, And to rhyming you don’t object! My research focuses on a specific gene, Over…
Author: Dr Mustafa M. Munye, 6th May 2020 A recent paper from Carl June’s lab published in the journal Science¹ described results of a University of Pennsylvania clinical trial that administered in three patients T-cells engineered to target cancer cells…
Author: Dr Christos Georgiadis, 18th December 2019 A broad range of genome editing tools are currently available enabling targeted scission at a predetermined DNA locus. The field has exploded with the invention of CRISPR allowing scientists to cheaply and rapidly…
Author: Alexander Baker, 26th November 2019 Carefully modified viruses are becoming major new drugs in the battle against cancer. The idea is that the viruses can be re-engineered so instead of attacking healthy cells and causing disease, they only attack…
Author: Robyn Bell, 14th October 2019 Injuries to tendons, the tissue that links muscle to bone, are commonly seen in the clinic yet few strategies exist to improve upon slow and largely poor tendon healing standards. Published in the September…
Author: Professor Sian Harding, 30th September 2019 Tissue engineering for cardiac repair has reached an advanced stage and engineered constructs are starting to be approved for first-in-human trials. This has been driven by positive factors such as the marked improvement…